Clinical Trials Directory

Trials / Conditions / Thyroid Gland Anaplastic Carcinoma

Thyroid Gland Anaplastic Carcinoma

9 registered clinical trials studyying Thyroid Gland Anaplastic Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
Recruiting[177Lu]Lu-AKIR001 First-in-human Study
NCT06639191
Karolinska University HospitalEARLY_Phase 1
Active Not RecruitingPembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid
NCT04675710
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingSelpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
M.D. Anderson Cancer CenterPhase 2
WithdrawnDabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer
NCT04739566
Saint Petersburg State University, RussiaPhase 2
RecruitingDabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
NCT03975231
City of Hope Medical CenterPhase 1
Active Not RecruitingLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca
NCT03449108
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingAtezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
M.D. Anderson Cancer CenterPhase 2
CompletedIntensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patie
NCT01236547
National Cancer Institute (NCI)Phase 2
CompletedPazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
NCT00625846
National Cancer Institute (NCI)Phase 2